DORMAN PRODUCTS INC (DORM) Stock Fundamental Analysis

NASDAQ:DORM • US2582781009

131.17 USD
-0.51 (-0.39%)
At close: Feb 13, 2026
131.17 USD
0 (0%)
After Hours: 2/13/2026, 4:30:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

DORM gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 41 industry peers in the Automobile Components industry. DORM gets an excellent profitability rating and is at the same time showing great financial health properties. DORM is not valued too expensively and it also shows a decent growth rate. These ratings would make DORM suitable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • DORM had positive earnings in the past year.
  • DORM had a positive operating cash flow in the past year.
  • In the past 5 years DORM has always been profitable.
  • Each year in the past 5 years DORM had a positive operating cash flow.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

  • DORM has a better Return On Assets (9.70%) than 90.70% of its industry peers.
  • With an excellent Return On Equity value of 16.70%, DORM belongs to the best of the industry, outperforming 90.70% of the companies in the same industry.
  • DORM has a better Return On Invested Capital (13.16%) than 90.70% of its industry peers.
  • DORM had an Average Return On Invested Capital over the past 3 years of 9.34%. This is in line with the industry average of 9.03%.
  • The 3 year average ROIC (9.34%) for DORM is below the current ROIC(13.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.7%
ROE 16.7%
ROIC 13.16%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • With an excellent Profit Margin value of 11.65%, DORM belongs to the best of the industry, outperforming 97.67% of the companies in the same industry.
  • In the last couple of years the Profit Margin of DORM has grown nicely.
  • DORM has a Operating Margin of 16.71%. This is amongst the best in the industry. DORM outperforms 97.67% of its industry peers.
  • DORM's Operating Margin has improved in the last couple of years.
  • DORM's Gross Margin of 41.88% is amongst the best of the industry. DORM outperforms 86.05% of its industry peers.
  • DORM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.71%
PM (TTM) 11.65%
GM 41.88%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • DORM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • DORM has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for DORM has been reduced compared to 5 years ago.
  • The debt/assets ratio for DORM has been reduced compared to a year ago.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • DORM has an Altman-Z score of 4.76. This indicates that DORM is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of DORM (4.76) is better than 86.05% of its industry peers.
  • DORM has a debt to FCF ratio of 4.33. This is a neutral value as DORM would need 4.33 years to pay back of all of its debts.
  • The Debt to FCF ratio of DORM (4.33) is better than 69.77% of its industry peers.
  • A Debt/Equity ratio of 0.28 indicates that DORM is not too dependend on debt financing.
  • DORM has a Debt to Equity ratio of 0.28. This is in the better half of the industry: DORM outperforms 65.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 4.33
Altman-Z 4.76
ROIC/WACC1.42
WACC9.24%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 2.94 indicates that DORM has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.94, DORM is in the better half of the industry, outperforming 74.42% of the companies in the same industry.
  • A Quick Ratio of 1.19 indicates that DORM should not have too much problems paying its short term obligations.
  • DORM has a Quick ratio (1.19) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.94
Quick Ratio 1.19
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • DORM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.71%, which is quite impressive.
  • Measured over the past years, DORM shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.83% on average per year.
  • Looking at the last year, DORM shows a small growth in Revenue. The Revenue has grown by 7.94% in the last year.
  • The Revenue has been growing by 15.18% on average over the past years. This is quite good.
EPS 1Y (TTM)36.71%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%33.67%
Revenue 1Y (TTM)7.94%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.93%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.80% on average over the next years.
  • Based on estimates for the next years, DORM will show a small growth in Revenue. The Revenue will grow by 6.18% on average per year.
EPS Next Y26.13%
EPS Next 2Y16.42%
EPS Next 3Y15.1%
EPS Next 5Y7.8%
Revenue Next Year8.38%
Revenue Next 2Y6.73%
Revenue Next 3Y6.19%
Revenue Next 5Y6.18%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 14.74, DORM is valued correctly.
  • 67.44% of the companies in the same industry are more expensive than DORM, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 26.68. DORM is valued slightly cheaper when compared to this.
  • A Price/Forward Earnings ratio of 13.56 indicates a correct valuation of DORM.
  • The rest of the industry has a similar Price/Forward Earnings ratio as DORM.
  • DORM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 14.74
Fwd PE 13.56
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DORM is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, DORM is valued a bit more expensive than the industry average as 60.47% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 38.11
EV/EBITDA 10.72
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • DORM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of DORM may justify a higher PE ratio.
  • DORM's earnings are expected to grow with 15.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.56
PEG (5Y)0.68
EPS Next 2Y16.42%
EPS Next 3Y15.1%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for DORM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DORMAN PRODUCTS INC

NASDAQ:DORM (2/13/2026, 4:30:01 PM)

After market: 131.17 0 (0%)

131.17

-0.51 (-0.39%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)10-27
Earnings (Next)02-25
Inst Owners87.15%
Inst Owner Change-91.19%
Ins Owners13.6%
Ins Owner Change-1.28%
Market Cap4.01B
Revenue(TTM)2.13B
Net Income(TTM)247.63M
Analysts82.86
Price Target173.78 (32.48%)
Short Float %4.38%
Short Ratio6.29
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.25%
Min EPS beat(2)2.92%
Max EPS beat(2)11.58%
EPS beat(4)4
Avg EPS beat(4)15.07%
Min EPS beat(4)2.92%
Max EPS beat(4)36.11%
EPS beat(8)8
Avg EPS beat(8)23.63%
EPS beat(12)8
Avg EPS beat(12)10.09%
EPS beat(16)9
Avg EPS beat(16)7.08%
Revenue beat(2)1
Avg Revenue beat(2)-0.17%
Min Revenue beat(2)-3.26%
Max Revenue beat(2)2.92%
Revenue beat(4)2
Avg Revenue beat(4)0.68%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)3.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)3
Avg Revenue beat(12)-0.87%
Revenue beat(16)6
Avg Revenue beat(16)0.21%
PT rev (1m)-1.8%
PT rev (3m)1.34%
EPS NQ rev (1m)-0.06%
EPS NQ rev (3m)0.16%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)0.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.05%
Valuation
Industry RankSector Rank
PE 14.74
Fwd PE 13.56
P/S 1.89
P/FCF 38.11
P/OCF 28.03
P/B 2.7
P/tB 5.16
EV/EBITDA 10.72
EPS(TTM)8.9
EY6.79%
EPS(NY)9.68
Fwd EY7.38%
FCF(TTM)3.44
FCFY2.62%
OCF(TTM)4.68
OCFY3.57%
SpS69.57
BVpS48.51
TBVpS25.41
PEG (NY)0.56
PEG (5Y)0.68
Graham Number98.56
Profitability
Industry RankSector Rank
ROA 9.7%
ROE 16.7%
ROCE 17.45%
ROIC 13.16%
ROICexc 13.53%
ROICexgc 21.03%
OM 16.71%
PM (TTM) 11.65%
GM 41.88%
FCFM 4.95%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
ROICexc(3y)9.58%
ROICexc(5y)10.64%
ROICexgc(3y)16.14%
ROICexgc(5y)16.08%
ROCE(3y)13.07%
ROCE(5y)14.22%
ROICexgc growth 3Y8.15%
ROICexgc growth 5Y10.63%
ROICexc growth 3Y3.74%
ROICexc growth 5Y2.76%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
F-Score7
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 4.33
Debt/EBITDA 1.02
Cap/Depr 67.78%
Cap/Sales 1.78%
Interest Coverage 11.7
Cash Conversion 34.78%
Profit Quality 42.47%
Current Ratio 2.94
Quick Ratio 1.19
Altman-Z 4.76
F-Score7
WACC9.24%
ROIC/WACC1.42
Cap/Depr(3y)78.22%
Cap/Depr(5y)67.78%
Cap/Sales(3y)2.14%
Cap/Sales(5y)1.86%
Profit Quality(3y)77.16%
Profit Quality(5y)84.08%
High Growth Momentum
Growth
EPS 1Y (TTM)36.71%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%33.67%
EPS Next Y26.13%
EPS Next 2Y16.42%
EPS Next 3Y15.1%
EPS Next 5Y7.8%
Revenue 1Y (TTM)7.94%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.93%
Revenue Next Year8.38%
Revenue Next 2Y6.73%
Revenue Next 3Y6.19%
Revenue Next 5Y6.18%
EBIT growth 1Y25.27%
EBIT growth 3Y19.51%
EBIT growth 5Y22.59%
EBIT Next Year38.49%
EBIT Next 3Y15.9%
EBIT Next 5YN/A
FCF growth 1Y-8.15%
FCF growth 3Y33.52%
FCF growth 5Y23.87%
OCF growth 1Y-11.46%
OCF growth 3Y32.07%
OCF growth 5Y19.38%

DORMAN PRODUCTS INC / DORM FAQ

What is the ChartMill fundamental rating of DORMAN PRODUCTS INC (DORM) stock?

ChartMill assigns a fundamental rating of 7 / 10 to DORM.


Can you provide the valuation status for DORMAN PRODUCTS INC?

ChartMill assigns a valuation rating of 6 / 10 to DORMAN PRODUCTS INC (DORM). This can be considered as Fairly Valued.


What is the profitability of DORM stock?

DORMAN PRODUCTS INC (DORM) has a profitability rating of 9 / 10.


Can you provide the financial health for DORM stock?

The financial health rating of DORMAN PRODUCTS INC (DORM) is 7 / 10.


How sustainable is the dividend of DORMAN PRODUCTS INC (DORM) stock?

The dividend rating of DORMAN PRODUCTS INC (DORM) is 0 / 10 and the dividend payout ratio is 0%.